1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...
Cancer Research | 85 | 8_Supplement_1 | April 2025Journal Archive Cancer Research (1941-Present; volumes 1-current) Published twice monthly since 1987. From 1941-1986, published monthly. (ISSN ...
Abstract. Binding of steroid hormones to their cognate receptors regulates the growth of most prostate and breast cancers. We hypothesized that CYP11A inhibition might halt the synthesis of all ...
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, Seoul, Republic of Korea.
Cancer Res (2023) 83 (8_Supplement): LB031.
1Department of Medical Oncology, Gustave Roussy, Villejuif, France.
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, Massachusetts. *Corresponding Author: Serena C. Houghton, Department of Biostatistics and Epidemiology, ...
1Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York. 2Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
Cancer Res (2023) 83 (7_Supplement): ND02.